Human Metabolome Technologies, Inc. provided consolidated earnings guidance for the year ending June 30, 2022. For the year ending June 30, 2022, the company expects consolidated net sales to be JPY 1,200 million, operating profit to be JPY 120 million, profit attributable to owners of parent to be JPY 120 million and basic earnings per share to be JPY 20.34.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
651 JPY | -1.66% | +1.09% | +1.72% |
1st Jan change | Capi. | |
---|---|---|
+1.72% | 25.09M | |
+40.97% | 54.04B | |
+43.57% | 41.96B | |
-1.21% | 41.92B | |
-7.59% | 28.35B | |
+12.45% | 26.35B | |
-22.11% | 19B | |
+7.81% | 13B | |
+28.48% | 12.28B | |
+24.64% | 12.19B |
- Stock Market
- Equities
- 6090 Stock
- News Human Metabolome Technologies, Inc.
- Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022